Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Prakash Khadka

Showing results (1-10 of 16) with videos related to

Pageof 2
Sort By:
Germs|November 1, 2021
Alcohol-based hand sanitizer - composition, proper use and precautionsTushar Saha, Prakash Khadka, Shyamal C Das
Pharmaceutical Research|November 29, 2022
In vitro Dissolution Testing of Rifampicin Powder Formulations For Prediction of Plasma Concentration-Time Profiles After Inhaled DeliveryPrakash Khadka, Ian G Tucker, Shyamal C Das
Expert Opinion on Drug Delivery|January 5, 2024
The quest to deliver high-dose rifampicin: can the inhaled approach help?Prakash Khadka, Jack Dummer, Philip C Hill, et al.
International Journal of Pharmaceutics|July 10, 2018
Considerations in preparing for clinical studies of inhaled rifampicin to enhance tuberculosis treatmentPrakash Khadka, Jack Dummer, Philip C Hill, et al.
Pharmaceutics|September 28, 2023
Inhalable Combination Powder Formulations for Treating Latent and Multidrug-Resistant Tuberculosis: Formulation and In Vitro CharacterizationBasanth Babu Eedara, Claire Fan, Shubhra Sinha, et al.
Drug Delivery and Translational Research|September 21, 2022
A review of formulations and preclinical studies of inhaled rifampicin for its clinical translationPrakash Khadka, Jack Dummer, Philip C Hill, et al.
International Journal of Molecular Sciences|January 25, 2020
Production of Extracellular Matrix Proteins in the Cytoplasm of <i>E. coli</i>: Making Giants in Tiny FactoriesAnil A Sohail, Madhuri Gaikwad, Prakash Khadka, et al.
International Journal of Pharmaceutics|July 15, 2020
A study on polymorphic forms of rifampicin for inhaled high dose delivery in tuberculosis treatmentPrakash Khadka, Philip C Hill, Boya Zhang, et al.
International Journal of Pharmaceutics|August 20, 2024
Development of a proliposomal pretomanid dry powder inhaler as a novel alternative approach for combating pulmonary tuberculosisNattanit Aekwattanaphol, Shyamal C Das, Prakash Khadka, et al.
Biomolecules & Therapeutics|May 22, 2015
Preclinical Pharmacokinetic Evaluation of β-Lapachone: Characteristics of Oral Bioavailability and First-Pass Metabolism in RatsIksoo Kim, Hyeongmin Kim, Jieun Ro, et al.
Pageof 2

Showing results (1-10 of 16) with videos related to

Sort By:
Pageof 2
Germs|November 1, 2021
Alcohol-based hand sanitizer - composition, proper use and precautionsTushar Saha, Prakash Khadka, Shyamal C Das
Pharmaceutical Research|November 29, 2022
In vitro Dissolution Testing of Rifampicin Powder Formulations For Prediction of Plasma Concentration-Time Profiles After Inhaled DeliveryPrakash Khadka, Ian G Tucker, Shyamal C Das
Expert Opinion on Drug Delivery|January 5, 2024
The quest to deliver high-dose rifampicin: can the inhaled approach help?Prakash Khadka, Jack Dummer, Philip C Hill, et al.
International Journal of Pharmaceutics|July 10, 2018
Considerations in preparing for clinical studies of inhaled rifampicin to enhance tuberculosis treatmentPrakash Khadka, Jack Dummer, Philip C Hill, et al.
Pharmaceutics|September 28, 2023
Inhalable Combination Powder Formulations for Treating Latent and Multidrug-Resistant Tuberculosis: Formulation and In Vitro CharacterizationBasanth Babu Eedara, Claire Fan, Shubhra Sinha, et al.
Drug Delivery and Translational Research|September 21, 2022
A review of formulations and preclinical studies of inhaled rifampicin for its clinical translationPrakash Khadka, Jack Dummer, Philip C Hill, et al.
International Journal of Molecular Sciences|January 25, 2020
Production of Extracellular Matrix Proteins in the Cytoplasm of <i>E. coli</i>: Making Giants in Tiny FactoriesAnil A Sohail, Madhuri Gaikwad, Prakash Khadka, et al.
International Journal of Pharmaceutics|July 15, 2020
A study on polymorphic forms of rifampicin for inhaled high dose delivery in tuberculosis treatmentPrakash Khadka, Philip C Hill, Boya Zhang, et al.
International Journal of Pharmaceutics|August 20, 2024
Development of a proliposomal pretomanid dry powder inhaler as a novel alternative approach for combating pulmonary tuberculosisNattanit Aekwattanaphol, Shyamal C Das, Prakash Khadka, et al.
Biomolecules & Therapeutics|May 22, 2015
Preclinical Pharmacokinetic Evaluation of β-Lapachone: Characteristics of Oral Bioavailability and First-Pass Metabolism in RatsIksoo Kim, Hyeongmin Kim, Jieun Ro, et al.
Pageof 2